Possible Malaria Vacine

allAfrica.com:

Clinical tests of a product candidate to be a vaccine against malaria, the RTS/ASO2A, that were carried out by the Manhica Health Reaserach Centyre, in the southern Mozambican province of Maputo, revealed its efficacy and safety to reduce this disease, that has been the main cause of deaths in Mozambique and in Africa at large.

This could be a huge benefit for all of sub-Saharan Africa. Despite the much publicised (and very real) aids tradegy in Africa, it is malaria that is the real killer there. Not only does it kill directly, but it also contributes greatly to the wide-spread poverty of the continent. Anything that can be done to reduce malaria will be a huge benefit.